Evidence map›Paper›PMID 33657227›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2021

COVID-19 Challenges Confronted by Smoking Cessation Clinical Trials for People Living With HIV: The Experience of Grantees of the US National Cancer Institute.

Robert Schnoll, Steven L Bernstein, Annette Kaufman, Robert Gross, Sheryl L Catz, Patricia A Cioe, Brian Hitsman, Stephanie L Marhefka, Lauren R Pacek, Damon J Vidrine and 6 more

Abstract read
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Robert SchnollDepartment of Psychiatry and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-4089-856X
Steven L BernsteinDepartment of Emergency Medicine, Yale Center for Implementation Science, Yale School of Medicine, New Haven, CT, USA.
Annette KaufmanTobacco Control Research Branch, National Cancer Institute, Bethesda, MD, USA.
Robert GrossCenter for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.
Sheryl L CatzBetty Irene Moore School of Nursing, University of California-Davis, Sacramento, CA, USA.
Patricia A CioeCenter for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA.
Brian HitsmanDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID 0000-0003-2346-4521
Stephanie L MarhefkaCollege of Public Health and Division of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Lauren R PacekDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.ORCID 0000-0002-1412-1765
Damon J VidrineDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA.
Roger VilardagaDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.ORCID 0000-0002-7252-4343
E Jennifer EdelmanYale School of Medicine and Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA.
Jennifer B McClureKaiser Permanente Washington Health Research Institute, Seattle, WA, USA.ORCID 0000-0002-2094-9147
Rebecca AshareDepartment of Psychiatry and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0003-4664-009X
Elizabeth LockhartCollege of Public Health, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Kristina CrothersVeterans Affairs Puget Sound Health Care System, and University of Washington, Seattle, WA, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH, DEBBIE M. CHENG · 1998 to 2026
$51.7M
Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
Randomized Controlled Trial of a Novel Smoking Cessation Application Tailored to Individuals with Serious Mental Illness.R01DA047301 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI VILARDAGA, ROGER · 2020 to 2024
$3.4M
Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIVR01CA243914 · NCI · UNIVERSITY OF PENNSYLVANIA · PI GROSS, ROBERT, SCHNOLL, ROBERT ADAM · 2019 to 2024
$3.4M
A SMART Approach to Treating Tobacco Use Disorder in Persons Living with HIVR01CA243910 · NCI · YALE UNIVERSITY · PI BERNSTEIN, STEVEN L, EDELMAN, E. JENNIFER · 2019 to 2024
$3.4M
Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living with HIVR01CA243907 · NCI · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI CROTHERS, KRISTINA ANNE · 2019 to 2025
$3.1M
Randomized Trial of Automated Video-Assisted Smoking Treatment for People Living with HIVR01CA243552 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI VIDRINE, DAMON J. · 2019 to 2024
$3.1M
The Positively Quit Trial: Addressing disproportionate smoking rates among people living with HIVR01CA243800 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI MARHEFKA, STEPHANIE LYNN · 2019 to 2024
$2.9M
A Peer Navigator Model to Improve Quit Attempts, Quitline Use, and Smoking Cessation Rates among HIV-positive smokersR21CA243906 · NCI · BROWN UNIVERSITY · PI CIOE, PATRICIA ANN · 2019 to 2020
$389k
Early-phase Studies of a Tailored Evidence-Based Smoking Cessation mHealth App for Persons Living with HIVR21CA243911 · NCI · DUKE UNIVERSITY · PI VILARDAGA, ROGER · 2019 to 2020
$385k
NCATS NIH HHS UL1 TR001863NCI NIH HHS R01 CA243552NCI NIH HHS R01 CA243800NCI NIH HHS R01 CA243907NCI NIH HHS R01 CA243910NCI NIH HHS R01 CA243914NCI NIH HHS R21 CA243906NCI NIH HHS R21 CA243911NIAID NIH HHS P30 AI042853NIAID NIH HHS P30 AI064518NIDA NIH HHS R01 DA047301
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HIV InfectionsNeoplasmsSmoking CessationHumansNational Cancer Institute (U.S.)SARS-CoV-2United States

Identifiers

PMID33657227
PMCPMC7989188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.